Progress For Asian Associations As Regulatory Roadmap Recognized

An industry-led grouping of research-based pharma associations from across Asia has held its latest annual meeting in Tokyo at which it reported modest but steady progress across initiatives in the regulatory and drug discovery areas as it seeks to get novel medicines to patients faster.

More from Focus On Asia

More from Scrip